therefore , it was suggested that measurement of serum iap could be , at least in part , useful in validating the histologic analysis of brain tumours , in following responses to treatment when used as a tumour indicator , and in monitoring the progress of the disease in patients in terms of performance status .
C0027651
tumour
C0012634
disease